Megan Sniecinski, Chief Operating Officer of Praxis Precision Medicines, Inc. (NASDAQ:PRAX), filed a Form 4 on November 18, 2026, disclosing the acquisition of 21 shares of common stock on November 13, 2026, through the company's Employee Stock Purchase Plan.

Key Highlights

  • Reporting Person: Megan Sniecinski, Chief Operating Officer of Praxis Precision Medicines, Inc.
  • Transaction Date: November 13, 2026
  • Shares Acquired: 21 shares of common stock, coded as an acquisition (A)
  • Price Per Share: $278.911
  • Beneficial Ownership Following Transaction: 28,685 shares held directly
  • Plan Exemption: The acquisition was reported as exempt under both Rule 16b-3(d) and Rule 16b-3(c) of the Securities Exchange Act

Praxis Precision Medicines COO Reports ESPP Share Acquisition

According to the Form 4 filing, Megan Sniecinski, the Chief Operating Officer of Praxis Precision Medicines, Inc., acquired 21 shares of the company's common stock on November 13, 2026, at a price of $278.911 per share. The filing indicates the transaction was made under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan.

The filing states that the shares "were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)." Following this transaction, the filing reports that Sniecinski directly holds 28,685 shares of Praxis Precision Medicines common stock. No derivative securities transactions were reported in Table II of the filing.

The Form 4 was filed by Megan Sniecinski, with the signature provided by Alex Nemiroff as Attorney-in-Fact, and was submitted to the SEC on November 18, 2026. The filing is listed on NASDAQ under the ticker symbol PRAX.

What Was Disclosed

The filing disclosed a single acquisition of 21 shares of Praxis Precision Medicines common stock by COO Megan Sniecinski on November 13, 2026, at $278.911 per share through the company's Employee Stock Purchase Plan, bringing her direct beneficial ownership to 28,685 shares.